157 related articles for article (PubMed ID: 15179412)
1. Peripheral neuropathy in patients treated with leflunomide.
Bonnel RA; Graham DJ
Clin Pharmacol Ther; 2004 Jun; 75(6):580-5. PubMed ID: 15179412
[TBL] [Abstract][Full Text] [Related]
2. Peripheral neuropathy associated with leflunomide: is there a risk patient profile?
Martin K; Bentaberry F; Dumoulin C; Miremont-Salamé G; Haramburu F; Dehais J; Schaeverbeke T
Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):74-8. PubMed ID: 16845649
[TBL] [Abstract][Full Text] [Related]
3. Leflunomide-induced peripheral neuropathy.
Kho LK; Kermode AG
J Clin Neurosci; 2007 Feb; 14(2):179-81. PubMed ID: 17107800
[TBL] [Abstract][Full Text] [Related]
4. Effect of leflunomide on the peripheral nerves in rheumatoid arthritis.
Richards BL; Spies J; McGill N; Richards GW; Vaile J; Bleasel JF; Youssef PP
Intern Med J; 2007 Feb; 37(2):101-7. PubMed ID: 17229252
[TBL] [Abstract][Full Text] [Related]
5. Dapsone-induced peripheral neuropathy. Case report and review.
Waldinger TP; Siegle RJ; Weber W; Voorhees JJ
Arch Dermatol; 1984 Mar; 120(3):356-9. PubMed ID: 6322702
[TBL] [Abstract][Full Text] [Related]
6. Peripheral neuropathy in patients with systemic rheumatic diseases treated with leflunomide.
Metzler C; Arlt AC; Gross WL; Brandt J
Ann Rheum Dis; 2005 Dec; 64(12):1798-800. PubMed ID: 16284351
[No Abstract] [Full Text] [Related]
7. The incidence of pancytopenia in patients taking leflunomide alone or with methotrexate.
McEwen J; Purcell PM; Hill RL; Calcino LJ; Riley CG
Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):65-73. PubMed ID: 16634119
[TBL] [Abstract][Full Text] [Related]
8. Peripheral neuropathy in patients with inflammatory bowel disease.
Gondim FA; Brannagan TH; Sander HW; Chin RL; Latov N
Brain; 2005 Apr; 128(Pt 4):867-79. PubMed ID: 15705608
[TBL] [Abstract][Full Text] [Related]
9. The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India.
van Brakel WH; Nicholls PG; Das L; Barkataki P; Suneetha SK; Jadhav RS; Maddali P; Lockwood DN; Wilder-Smith E; Desikan KV
Lepr Rev; 2005 Mar; 76(1):14-34. PubMed ID: 15881033
[TBL] [Abstract][Full Text] [Related]
10. Association of Paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancer.
Mielke S; Sparreboom A; Steinberg SM; Gelderblom H; Unger C; Behringer D; Mross K
Clin Cancer Res; 2005 Jul; 11(13):4843-50. PubMed ID: 16000582
[TBL] [Abstract][Full Text] [Related]
11. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
[TBL] [Abstract][Full Text] [Related]
12. Neuropathy associated with leflunomide: a case series.
Martin K; Bentaberry F; Dumoulin C; Longy-Boursier M; Lifermann F; Haramburu F; Dehais J; Schaeverbeke T; Bégaud B; Moore N
Ann Rheum Dis; 2005 Apr; 64(4):649-50. PubMed ID: 15769926
[No Abstract] [Full Text] [Related]
13. HMG-CoA-reductase inhibitors and neuropathy: reports to the Netherlands Pharmacovigilance Centre.
de Langen JJ; van Puijenbroek EP
Neth J Med; 2006 Oct; 64(9):334-8. PubMed ID: 17057271
[TBL] [Abstract][Full Text] [Related]
14. The natural history and long-term outcome of 57 limb sarcoidosis neuropathy cases.
Burns TM; Dyck PJ; Aksamit AJ; Dyck PJ
J Neurol Sci; 2006 May; 244(1-2):77-87. PubMed ID: 16524595
[TBL] [Abstract][Full Text] [Related]
15. Development of neuropathy in patients with myeloma treated with thalidomide: patterns of occurrence and the role of electrophysiologic monitoring.
Mileshkin L; Stark R; Day B; Seymour JF; Zeldis JB; Prince HM
J Clin Oncol; 2006 Sep; 24(27):4507-14. PubMed ID: 16940275
[TBL] [Abstract][Full Text] [Related]
16. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
17. Clinical and electrophysiological evaluation of patients with thalidomide-induced neuropathy.
Kocer B; Sucak G; Kuruoglu R; Aki Z; Haznedar R; Erdogmus NI
Acta Neurol Belg; 2009 Jun; 109(2):120-6. PubMed ID: 19681443
[TBL] [Abstract][Full Text] [Related]
18. Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib.
Richardson PG; Briemberg H; Jagannath S; Wen PY; Barlogie B; Berenson J; Singhal S; Siegel DS; Irwin D; Schuster M; Srkalovic G; Alexanian R; Rajkumar SV; Limentani S; Alsina M; Orlowski RZ; Najarian K; Esseltine D; Anderson KC; Amato AA
J Clin Oncol; 2006 Jul; 24(19):3113-20. PubMed ID: 16754936
[TBL] [Abstract][Full Text] [Related]
19. Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature.
Badros A; Goloubeva O; Dalal JS; Can I; Thompson J; Rapoport AP; Heyman M; Akpek G; Fenton RG
Cancer; 2007 Sep; 110(5):1042-9. PubMed ID: 17654660
[TBL] [Abstract][Full Text] [Related]
20. Age and height predict neuropathy risk in patients with HIV prescribed stavudine.
Cherry CL; Affandi JS; Imran D; Yunihastuti E; Smyth K; Vanar S; Kamarulzaman A; Price P
Neurology; 2009 Jul; 73(4):315-20. PubMed ID: 19636052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
